Aptt. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Organisms2

Diseases21

Blood Coagulation Disorders Hemorrhage Hypoprothrombinemias Blood Coagulation Disorders, Inherited Hemorrhagic Disorders Hemophilia A Thromboembolism Thrombosis Activated Protein C Resistance Hemostatic Disorders Hemophilia B Vitamin K Deficiency Disseminated Intravascular Coagulation Antiphospholipid Syndrome Thrombophilia Thrombocytopenia Dog Diseases Venous Thrombosis Lupus Erythematosus, Systemic Acute Disease Recurrence

Chemicals and Drugs34

Anticoagulants Heparin Lupus Coagulation Inhibitor Heparin Antagonists Antithrombins Pipecolic Acids Hirudins Blood Coagulation Factors Factor VIII Factor Xa Factor IX Thrombin Fibrinogen Coagulants Prothrombin Protein C Antithrombin III Hemostatics beta-Alanine Chromogenic Compounds Heparin, Low-Molecular-Weight Fibrinolytic Agents Indicators and Reagents Vitamin K Enoxaparin Thromboplastin Fibrin Fibrinogen Degradation Products Factor V Warfarin Benzimidazoles Recombinant Proteins Immunologic Factors Autoantibodies Peptide Fragments

Analytical, Diagnostic and Therapeutic Techniques and Equipment19

Partial Thromboplastin Time Prothrombin Time Blood Coagulation Tests Thrombin Time Hirudin Therapy Thrombelastography Whole Blood Coagulation Time Bleeding Time Platelet Count Drug Monitoring International Normalized Ratio Blood Specimen Collection Infusions, Intravenous Administration, Oral Clinical Laboratory Techniques Injections, Intravenous Reference Values Prospective Studies Treatment Outcome

Phenomena and Processes12

Partial Thromboplastin Time Prothrombin Time Thrombin Time Blood Coagulation Hemostasis Whole Blood Coagulation Time Bleeding Time Platelet Count Fibrinolysis Dose-Response Relationship, Drug Platelet Aggregation Time Factors

Health Care4

Population Laboratories Prospective Studies Treatment Outcome

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Health Care

Partial Thromboplastin Time Prothrombin Time Blood Coagulation Tests Thrombin Time Blood Coagulation Blood Coagulation Disorders Anticoagulants Heparin Hirudin Therapy Lupus Coagulation Inhibitor Thrombelastography Heparin Antagonists Antithrombins Pipecolic Acids Hirudins Hemorrhage Hypoprothrombinemias Hemostasis Whole Blood Coagulation Time Blood Coagulation Factors Factor VIII Factor Xa Blood Coagulation Disorders, Inherited Hemorrhagic Disorders Factor IX Hemophilia A Thrombin Thromboembolism Fibrinogen Bleeding Time Coagulants Prothrombin Platelet Count Thrombosis Protein C Activated Protein C Resistance Antithrombin III Hemostatic Disorders Hemostatics Hemophilia B Vitamin K Deficiency Drug Monitoring beta-Alanine Disseminated Intravascular Coagulation International Normalized Ratio Chromogenic Compounds Heparin, Low-Molecular-Weight Fibrinolytic Agents Indicators and Reagents Plasma Fibrinolysis Blood Specimen Collection Vitamin K Enoxaparin Thromboplastin Fibrin Fibrinogen Degradation Products Antiphospholipid Syndrome Thrombophilia Population Thrombocytopenia Dog Diseases Factor V Dose-Response Relationship, Drug Infusions, Intravenous Warfarin Dogs Benzimidazoles Venous Thrombosis Laboratories Recombinant Proteins Administration, Oral Clinical Laboratory Techniques Injections, Intravenous Reference Values Immunologic Factors Platelet Aggregation Prospective Studies Autoantibodies Time Factors Lupus Erythematosus, Systemic Treatment Outcome Rabbits Peptide Fragments Acute Disease Recurrence

No FAQ available that match "aptt"